Awm Investment Company Has Upped Dermira (DERM) Stake by $668,500 as Shares Declined; Validus Holdings LTD (VR) Valuation Rose While Petersen Flynn & Dinsmore Trimmed Holding

June 21, 2018 - By wolcottdaily

Dermira, Inc. (NASDAQ:DERM) Logo

Petersen Flynn & Dinsmore Inc decreased its stake in Validus Holdings Ltd (VR) by 6.28% based on its latest 2018Q1 regulatory filing with the SEC. Petersen Flynn & Dinsmore Inc sold 21,778 shares as the company’s stock rose 0.24% while stock markets declined. The institutional investor held 325,244 shares of the finance company at the end of 2018Q1, valued at $21.94 million, down from 347,022 at the end of the previous reported quarter. Petersen Flynn & Dinsmore Inc who had been investing in Validus Holdings Ltd for a number of months, seems to be less bullish one the $5.57B market cap company. The stock decreased 0.06% or $0.04 during the last trading session, reaching $67.84. About 458,887 shares traded. Validus Holdings, Ltd. (NYSE:VR) has risen 26.41% since June 21, 2017 and is uptrending. It has outperformed by 13.84% the S&P500. Some Historical VR News: 17/04/2018 – Carter Validus Mission Critical REIT Il, Inc. Acquires Approximately $51 Million Data Center Portfolio in Sacramento, California in the First Quarter of 2018; 01/05/2018 – Validus Holding: Book Value $44.14/Share at March 31; 14/05/2018 – Fidelity & Research Buys New 2.7% Position in Validus; 15/05/2018 – Magnetar Financial Buys New 3.6% Position in Validus; 21/04/2018 – DJ CARTER VALIDUS MISSION CRITICAL REI, Inst Holders, 1Q 2018 (CZMR); 30/05/2018 – EU mergers and takeovers (May 30); 01/05/2018 – VALIDUS 1Q OPER EPS 53C, EST. 97C; 15/05/2018 – CNH Partners Buys New 3% Position in Validus; 22/03/2018 – VALIDUS SPECIALTY UNDERWRITING SERVICES . – PARTNERSHIP WITH EAGLE OCEAN AMERICA, A FULL-SERVICE INSURANCE FACILITY OPERATED BY EAGLE OCEAN AGENCIES; 01/05/2018 – Validus Holding 1Q Gross Premiums Written $1.83 BIllion

Awm Investment Company Inc increased its stake in Dermira Inc. (DERM) by 95.02% based on its latest 2018Q1 regulatory filing with the SEC. Awm Investment Company Inc bought 95,500 shares as the company’s stock declined 68.37% with the market. The institutional investor held 196,000 shares of the health care company at the end of 2018Q1, valued at $1.57 million, up from 100,500 at the end of the previous reported quarter. Awm Investment Company Inc who had been investing in Dermira Inc. for a number of months, seems to be bullish on the $447.77 million market cap company. The stock decreased 0.93% or $0.1 during the last trading session, reaching $10.7. About 495,630 shares traded. Dermira, Inc. (NASDAQ:DERM) has declined 69.41% since June 21, 2017 and is downtrending. It has underperformed by 81.98% the S&P500. Some Historical DERM News: 03/04/2018 – UCB SA UCB.BR – PUBLICATION ON CIMZIA® SHOWS PSORIATIC ARTHRITIS PATIENTS ACHIEVED TREATMENT TARGETS; 03/05/2018 – DERMIRA INC – LEBRIKIZUMAB PHASE 2B STUDY ENROLLING PATIENTS, DATA EXPECTED IN FIRST HALF OF 2019; 30/03/2018 – UCB SA UCB.BR – CIMZIA IS NOT CURRENTLY MARKETED IN CHINA; 11/05/2018 – Loomis Sayles & Company LP Exits Position in Dermira; 14/05/2018 – Dermira to Host Analyst & Investor Day on May 24, 2018; 20/04/2018 – Jennison Associates LLC Exits Position in Dermira; 16/05/2018 – CIMZIA® (certolizumab pegol) is the First Therapy to Demonstrate Positive Results in a 52-week, Placebo Controlled Non-Radiographic Axial Spondyloarthritis Study; 03/05/2018 – Dermira 1Q Loss/Shr $1.42; 03/05/2018 – DERMIRA INC DERM.O – QTRLY SHR LOSS $1.42; 15/05/2018 – Orbimed Advisors LLC Exits Position in Dermira

Analysts await Validus Holdings, Ltd. (NYSE:VR) to report earnings on July, 26. They expect $1.20 EPS, up 10.09% or $0.11 from last year’s $1.09 per share. VR’s profit will be $98.54M for 14.13 P/E if the $1.20 EPS becomes a reality. After $0.53 actual EPS reported by Validus Holdings, Ltd. for the previous quarter, Wall Street now forecasts 126.42% EPS growth.

Among 9 analysts covering Validus Holdings (NYSE:VR), 2 have Buy rating, 0 Sell and 7 Hold. Therefore 22% are positive. Validus Holdings had 20 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Validus Holdings, Ltd. (NYSE:VR) earned “Buy” rating by Bank of America on Monday, October 30. Wood downgraded Validus Holdings, Ltd. (NYSE:VR) on Tuesday, January 23 to “Market Perform” rating. The firm has “Hold” rating given on Friday, April 28 by Wood. UBS maintained Validus Holdings, Ltd. (NYSE:VR) rating on Monday, October 30. UBS has “Neutral” rating and $52 target. The company was downgraded on Friday, September 23 by UBS. The rating was upgraded by Keefe Bruyette & Woods on Thursday, January 4 to “Buy”. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Friday, June 2. The stock of Validus Holdings, Ltd. (NYSE:VR) has “Hold” rating given on Tuesday, January 30 by JMP Securities. The stock of Validus Holdings, Ltd. (NYSE:VR) earned “Hold” rating by Deutsche Bank on Monday, February 6. The firm has “Hold” rating by Keefe Bruyette & Woods given on Monday, January 22.

Investors sentiment decreased to 0.76 in Q1 2018. Its down 0.17, from 0.93 in 2017Q4. It dropped, as 56 investors sold VR shares while 74 reduced holdings. 62 funds opened positions while 37 raised stakes. 60.91 million shares or 19.41% less from 75.58 million shares in 2017Q4 were reported. Parkside Retail Bank And invested in 0.02% or 777 shares. Tokio Marine Asset Mngmt reported 75,052 shares. Signaturefd Limited Liability Corporation owns 1,656 shares for 0.01% of their portfolio. Royal Natl Bank Of Canada holds 0.01% or 374,575 shares in its portfolio. P Schoenfeld Asset Management Lp invested in 1.84% or 466,410 shares. Moab Cap Partners Lc accumulated 130,698 shares or 1.94% of the stock. Legal & General Gru Public Ltd Company reported 76,789 shares. Rafferty Asset Mgmt Limited has 0.02% invested in Validus Holdings, Ltd. (NYSE:VR) for 19,670 shares. Ubs Asset Mgmt Americas invested 0% in Validus Holdings, Ltd. (NYSE:VR). Stifel Fincl invested in 21,920 shares. Minnesota-based Gradient Invests Ltd Limited Liability Company has invested 0% in Validus Holdings, Ltd. (NYSE:VR). Koch owns 106,490 shares for 0.73% of their portfolio. Virtu Ltd Llc holds 4,738 shares or 0.02% of its portfolio. Commonwealth Of Pennsylvania Pub School Empls Retrmt System invested 0.17% of its portfolio in Validus Holdings, Ltd. (NYSE:VR). Hsbc Public Limited Co holds 0% in Validus Holdings, Ltd. (NYSE:VR) or 5,439 shares.

Petersen Flynn & Dinsmore Inc, which manages about $572.13 million and $607.22 million US Long portfolio, upped its stake in Hcp Inc (NYSE:HCP) by 56,525 shares to 640,611 shares, valued at $14.88 million in 2018Q1, according to the filing. It also increased its holding in Verizon Communications Inc (NYSE:VZ) by 13,094 shares in the quarter, for a total of 444,745 shares, and has risen its stake in Amgen Inc (NASDAQ:AMGN).

Since January 16, 2018, it had 0 insider purchases, and 8 insider sales for $4.02 million activity. $697,781 worth of Validus Holdings, Ltd. (NYSE:VR) was sold by Carpenter Michael E.A. on Friday, March 9.

Awm Investment Company Inc, which manages about $1.06B and $518.61 million US Long portfolio, decreased its stake in Lemaitre Vascular Inc. (NASDAQ:LMAT) by 150,000 shares to 353,794 shares, valued at $12.82M in 2018Q1, according to the filing. It also reduced its holding in Axogen Inc. (NASDAQ:AXGN) by 20,000 shares in the quarter, leaving it with 261,506 shares, and cut its stake in Vocera Communications Inc. (NYSE:VCRA).

Since January 2, 2018, it had 1 buy, and 8 selling transactions for $671,060 activity. 600 shares were sold by Cohen David E, worth $17,322 on Thursday, February 1. WIGGANS THOMAS G bought $119,954 worth of stock or 11,875 shares. $499,354 worth of stock was sold by Griffith Christopher M. on Tuesday, January 2.

More recent Dermira, Inc. (NASDAQ:DERM) news were published by: Nasdaq.com which released: “Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)” on June 08, 2018. Also Fool.com published the news titled: “Here’s Why Dermira Inc Stock Fell More Than 23% Today” on May 24, 2018. Seekingalpha.com‘s news article titled: “Key events next week – healthcare” with publication date: June 21, 2018 was also an interesting one.

Investors sentiment decreased to 1.08 in 2018 Q1. Its down 0.19, from 1.27 in 2017Q4. It worsened, as 30 investors sold DERM shares while 30 reduced holdings. 31 funds opened positions while 34 raised stakes. 34.74 million shares or 10.50% less from 38.81 million shares in 2017Q4 were reported. Moreover, Northern Trust Corporation has 0% invested in Dermira, Inc. (NASDAQ:DERM) for 440,933 shares. 10,961 are owned by Aperio Ltd Company. First Trust LP invested in 20,558 shares. Blackrock invested in 3.59M shares or 0% of the stock. Credit Suisse Ag invested in 0% or 47,651 shares. Quantbot Lp holds 0.03% or 38,146 shares in its portfolio. Sio Capital Ltd Liability, New York-based fund reported 190,300 shares. Legal General Public Limited Com has invested 0% in Dermira, Inc. (NASDAQ:DERM). Manufacturers Life Insurance The has invested 0% in Dermira, Inc. (NASDAQ:DERM). Alliancebernstein Lp reported 61,520 shares. California State Teachers Retirement has invested 0% in Dermira, Inc. (NASDAQ:DERM). Alyeska Gp Limited Partnership invested in 0.01% or 100,156 shares. New York State Common Retirement Fund stated it has 0% of its portfolio in Dermira, Inc. (NASDAQ:DERM). Zurcher Kantonalbank (Zurich Cantonalbank) reported 1,873 shares. Awm Invest, a New York-based fund reported 196,000 shares.

Dermira, Inc. (NASDAQ:DERM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts